CrossrefInfokarte
Tailored HER2 ECD mRNA-LNP vaccines boost CD8+ T cell-mediated antitumor immunity for HER2-positive tumor suppression
Drug Resistance Updates · 2026-09 · 88 · 101439
DOI: 10.1016/j.drup.2026.101439 ↗Abstract
Kein Abstract verfügbar.
EUVIMED